Description
An azapeptide inhibitor of HIV-1 protease (Ki = 2.66 nM). It has antiviral activity against a variety of HIV-1 strains in several cell types (EC50 = 2.62-5.28 nM); exhibits a minor synergistic effect when used in combination with zidovudine in HIV-1-infected human PBMCs and an additive effect when used in combination with several additional reverse transcriptase or HIV-1 protease inhibitors; inhibits UGT1A1, which is involved in bilirubin clearance
Formal name: 3S,12S-bis(1,1-dimethylethyl)-8S-hydroxy-4,11-dioxo-9S-(phenylmethyl)-6-[[4-(2-pyridinyl)phenyl]methyl]-2,5,6,10,13-pentaazatetradecanedioic acid, 1,14-dimethyl ester
Synonyms: BMS 232632|CGP 73547
Molecular weight: 704.9
CAS: 198904-31-3
Purity: ≥95%
Formulation: A crystalline solid
Product Type|Biochemicals|Antivirals|Protease Inhibitors||Product Type|Biochemicals|Small Molecule Inhibitors|Peptidases & Proteases||Research Area|Immunology & Inflammation||Research Area|Infectious Disease|Viral Diseases|HIV & AIDS